Evidence map›Paper›PMID 27089853›Full record

ArticleScientific reports2016

A reliable Raman-spectroscopy-based approach for diagnosis, classification and follow-up of B-cell acute lymphoblastic leukemia.

Stefano Managò, Carmen Valente, Peppino Mirabelli, Diego Circolo, Filomena Basile, Daniela Corda, Anna Chiara De Luca

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
15.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Stefano ManagòInstitute of Protein Biochemistry, National Research Council, Via P. Castellino 111, 80131 Naples, Italy.
Carmen ValenteInstitute of Protein Biochemistry, National Research Council, Via P. Castellino 111, 80131 Naples, Italy.
Peppino MirabelliIRCCS SDN Istituto di Ricerca Diagnostica e Nucleare, Via E. Gianturco 113, 80143 Naples, Italy.
Diego CircoloInstitute of Protein Biochemistry, National Research Council, Via P. Castellino 111, 80131 Naples, Italy.
Filomena BasileUOSC Servizio di Immunoematologia e Medicina Trasfusionale, AORN Cardarelli Hospital, Via A. Cardarelli 9, 80131, Naples, Italy.
Daniela CordaInstitute of Protein Biochemistry, National Research Council, Via P. Castellino 111, 80131 Naples, Italy.
Anna Chiara De LucaInstitute of Protein Biochemistry, National Research Council, Via P. Castellino 111, 80131 Naples, Italy.
Institute of Protein Biochemistry · ITOspedale Antonio Cardarelli · ITSDN Istituto di Ricerca Diagnostica e Nucleare · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute lymphoblastic leukemia type B (B-ALL) is a neoplastic disorder that shows high mortality rates due to immature lymphocyte B-cell proliferation. B-ALL diagnosis requires identification and classification of the leukemia cells. Here, we demonstrate the use of Raman spectroscopy to discriminate normal lymphocytic B-cells from three different B-leukemia transformed cell lines (i.e., RS4;11, REH, MN60 cells) based on their biochemical features. In combination with immunofluorescence and Western blotting, we show that these Raman markers reflect the relative changes in the potential biological markers from cell surface antigens, cytoplasmic proteins, and DNA content and correlate with the lymphoblastic B-cell maturation/differentiation stages. Our study demonstrates the potential of this technique for classification of B-leukemia cells into the different differentiation/maturation stages, as well as for the identification of key biochemical changes under chemotherapeutic treatments. Finally, preliminary results from clinical samples indicate high consistency of, and potential applications for, this Raman spectroscopy approach.

Indexed as

Leukemia, B-CellPrecursor Cell Lymphoblastic Leukemia-LymphomaSpectrum Analysis, RamanAntineoplastic AgentsCell DifferentiationCell Line, TumorHumansImmunophenotypingAntineoplastic Agents

Identifiers

PMID27089853
PMCPMC4835730
OpenAlexW2337133817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.